Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Inflammatory Bowel Disease Treatment Market, by Type
1.4.2 Global Inflammatory Bowel Disease Treatment Market, by Distribution Channel
1.4.3 Global Inflammatory Bowel Disease Treatment Market, by Route of Administration
1.4.4 Global Inflammatory Bowel Disease Treatment Market, by Drug Class
1.4.5 Global Inflammatory Bowel Disease Treatment Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Approvals and Trials : 2017, Aug – 2021, Sep) Leading Players
Chapter 4. Global Inflammatory Bowel Disease Treatment Market by Type
4.1 Global Crohn's Disease Market by Region
4.2 Global Ulcerative Colitis Market by Region
4.3 Global Inflammatory Bowel Disease Treatment Market by Distribution Channel
4.4 Global Hospital Pharmacy Market by Region
4.5 Global Retail Pharmacy Market by Region
4.6 Global Online Pharmacy Market by Region
Chapter 5. Global Inflammatory Bowel Disease Treatment Market by Route of Administration
5.1 Global Injectable Market by Region
5.2 Global Oral Market by Region
Chapter 6. Global Inflammatory Bowel Disease Treatment Market by Drug Class
6.1 Global TNF inhibitors Market by Region
6.2 Global Anti-integrin Market by Region
6.3 Global IL inhibitors Market by Region
6.4 Global Corticosteroids Market by Region
6.5 Global JAK inhibitors Market by Region
6.6 Global Aminosalicylates Market by Region
6.7 Global Others Market by Region
Chapter 7. Global Inflammatory Bowel Disease Treatment Market by Region
7.1 North America Inflammatory Bowel Disease Treatment Market
7.1.1 North America Inflammatory Bowel Disease Treatment Market by Type
7.1.1.1 North America Crohn's Disease Market by Country
7.1.1.2 North America Ulcerative Colitis Market by Country
7.1.2 North America Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.1.2.1 North America Hospital Pharmacy Market by Country
7.1.2.2 North America Retail Pharmacy Market by Country
7.1.2.3 North America Online Pharmacy Market by Country
7.1.3 North America Inflammatory Bowel Disease Treatment Market by Route of Administration
7.1.3.1 North America Injectable Market by Country
7.1.3.2 North America Oral Market by Country
7.1.4 North America Inflammatory Bowel Disease Treatment Market by Drug Class
7.1.4.1 North America TNF inhibitors Market by Country
7.1.4.2 North America Anti-integrin Market by Country
7.1.4.3 North America IL inhibitors Market by Country
7.1.4.4 North America Corticosteroids Market by Country
7.1.4.5 North America JAK inhibitors Market by Country
7.1.4.6 North America Aminosalicylates Market by Country
7.1.4.7 North America Others Market by Country
7.1.5 North America Inflammatory Bowel Disease Treatment Market by Country
7.1.5.1 US Inflammatory Bowel Disease Treatment Market
7.1.5.1.1 US Inflammatory Bowel Disease Treatment Market by Type
7.1.5.1.2 US Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.1.5.1.3 US Inflammatory Bowel Disease Treatment Market by Route of Administration
7.1.5.1.4 US Inflammatory Bowel Disease Treatment Market by Drug Class
7.1.5.2 Canada Inflammatory Bowel Disease Treatment Market
7.1.5.2.1 Canada Inflammatory Bowel Disease Treatment Market by Type
7.1.5.2.2 Canada Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.1.5.2.3 Canada Inflammatory Bowel Disease Treatment Market by Route of Administration
7.1.5.2.4 Canada Inflammatory Bowel Disease Treatment Market by Drug Class
7.1.5.3 Mexico Inflammatory Bowel Disease Treatment Market
7.1.5.3.1 Mexico Inflammatory Bowel Disease Treatment Market by Type
7.1.5.3.2 Mexico Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.1.5.3.3 Mexico Inflammatory Bowel Disease Treatment Market by Route of Administration
7.1.5.3.4 Mexico Inflammatory Bowel Disease Treatment Market by Drug Class
7.1.5.4 Rest of North America Inflammatory Bowel Disease Treatment Market
7.1.5.4.1 Rest of North America Inflammatory Bowel Disease Treatment Market by Type
7.1.5.4.2 Rest of North America Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.1.5.4.3 Rest of North America Inflammatory Bowel Disease Treatment Market by Route of Administration
7.1.5.4.4 Rest of North America Inflammatory Bowel Disease Treatment Market by Drug Class
7.2 Europe Inflammatory Bowel Disease Treatment Market
7.2.1 Europe Inflammatory Bowel Disease Treatment Market by Type
7.2.1.1 Europe Crohn's Disease Market by Country
7.2.1.2 Europe Ulcerative Colitis Market by Country
7.2.2 Europe Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.2.2.1 Europe Hospital Pharmacy Market by Country
7.2.2.2 Europe Retail Pharmacy Market by Country
7.2.2.3 Europe Online Pharmacy Market by Country
7.2.3 Europe Inflammatory Bowel Disease Treatment Market by Route of Administration
7.2.3.1 Europe Injectable Market by Country
7.2.3.2 Europe Oral Market by Country
7.2.4 Europe Inflammatory Bowel Disease Treatment Market by Drug Class
7.2.4.1 Europe TNF inhibitors Market by Country
7.2.4.2 Europe Anti-integrin Market by Country
7.2.4.3 Europe IL inhibitors Market by Country
7.2.4.4 Europe Corticosteroids Market by Country
7.2.4.5 Europe JAK inhibitors Market by Country
7.2.4.6 Europe Aminosalicylates Market by Country
7.2.4.7 Europe Others Market by Country
7.2.5 Europe Inflammatory Bowel Disease Treatment Market by Country
7.2.5.1 Germany Inflammatory Bowel Disease Treatment Market
7.2.5.1.1 Germany Inflammatory Bowel Disease Treatment Market by Type
7.2.5.1.2 Germany Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.2.5.1.3 Germany Inflammatory Bowel Disease Treatment Market by Route of Administration
7.2.5.1.4 Germany Inflammatory Bowel Disease Treatment Market by Drug Class
7.2.5.2 UK Inflammatory Bowel Disease Treatment Market
7.2.5.2.1 UK Inflammatory Bowel Disease Treatment Market by Type
7.2.5.2.2 UK Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.2.5.2.3 UK Inflammatory Bowel Disease Treatment Market by Route of Administration
7.2.5.2.4 UK Inflammatory Bowel Disease Treatment Market by Drug Class
7.2.5.3 France Inflammatory Bowel Disease Treatment Market
7.2.5.3.1 France Inflammatory Bowel Disease Treatment Market by Type
7.2.5.3.2 France Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.2.5.3.3 France Inflammatory Bowel Disease Treatment Market by Route of Administration
7.2.5.3.4 France Inflammatory Bowel Disease Treatment Market by Drug Class
7.2.5.4 Russia Inflammatory Bowel Disease Treatment Market
7.2.5.4.1 Russia Inflammatory Bowel Disease Treatment Market by Type
7.2.5.4.2 Russia Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.2.5.4.3 Russia Inflammatory Bowel Disease Treatment Market by Route of Administration
7.2.5.4.4 Russia Inflammatory Bowel Disease Treatment Market by Drug Class
7.2.5.5 Spain Inflammatory Bowel Disease Treatment Market
7.2.5.5.1 Spain Inflammatory Bowel Disease Treatment Market by Type
7.2.5.5.2 Spain Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.2.5.5.3 Spain Inflammatory Bowel Disease Treatment Market by Route of Administration
7.2.5.5.4 Spain Inflammatory Bowel Disease Treatment Market by Drug Class
7.2.5.6 Italy Inflammatory Bowel Disease Treatment Market
7.2.5.6.1 Italy Inflammatory Bowel Disease Treatment Market by Type
7.2.5.6.2 Italy Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.2.5.6.3 Italy Inflammatory Bowel Disease Treatment Market by Route of Administration
7.2.5.6.4 Italy Inflammatory Bowel Disease Treatment Market by Drug Class
7.2.5.7 Rest of Europe Inflammatory Bowel Disease Treatment Market
7.2.5.7.1 Rest of Europe Inflammatory Bowel Disease Treatment Market by Type
7.2.5.7.2 Rest of Europe Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.2.5.7.3 Rest of Europe Inflammatory Bowel Disease Treatment Market by Route of Administration
7.2.5.7.4 Rest of Europe Inflammatory Bowel Disease Treatment Market by Drug Class
7.3 Asia Pacific Inflammatory Bowel Disease Treatment Market
7.3.1 Asia Pacific Inflammatory Bowel Disease Treatment Market by Type
7.3.1.1 Asia Pacific Crohn's Disease Market by Country
7.3.1.2 Asia Pacific Ulcerative Colitis Market by Country
7.3.2 Asia Pacific Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.3.2.1 Asia Pacific Hospital Pharmacy Market by Country
7.3.2.2 Asia Pacific Retail Pharmacy Market by Country
7.3.2.3 Asia Pacific Online Pharmacy Market by Country
7.3.3 Asia Pacific Inflammatory Bowel Disease Treatment Market by Route of Administration
7.3.3.1 Asia Pacific Injectable Market by Country
7.3.3.2 Asia Pacific Oral Market by Country
7.3.4 Asia Pacific Inflammatory Bowel Disease Treatment Market by Drug Class
7.3.4.1 Asia Pacific TNF inhibitors Market by Country
7.3.4.2 Asia Pacific Anti-integrin Market by Country
7.3.4.3 Asia Pacific IL inhibitors Market by Country
7.3.4.4 Asia Pacific Corticosteroids Market by Country
7.3.4.5 Asia Pacific JAK inhibitors Market by Country
7.3.4.6 Asia Pacific Aminosalicylates Market by Country
7.3.4.7 Asia Pacific Others Market by Country
7.3.5 Asia Pacific Inflammatory Bowel Disease Treatment Market by Country
7.3.5.1 China Inflammatory Bowel Disease Treatment Market
7.3.5.1.1 China Inflammatory Bowel Disease Treatment Market by Type
7.3.5.1.2 China Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.3.5.1.3 China Inflammatory Bowel Disease Treatment Market by Route of Administration
7.3.5.1.4 China Inflammatory Bowel Disease Treatment Market by Drug Class
7.3.5.2 Japan Inflammatory Bowel Disease Treatment Market
7.3.5.2.1 Japan Inflammatory Bowel Disease Treatment Market by Type
7.3.5.2.2 Japan Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.3.5.2.3 Japan Inflammatory Bowel Disease Treatment Market by Route of Administration
7.3.5.2.4 Japan Inflammatory Bowel Disease Treatment Market by Drug Class
7.3.5.3 India Inflammatory Bowel Disease Treatment Market
7.3.5.3.1 India Inflammatory Bowel Disease Treatment Market by Type
7.3.5.3.2 India Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.3.5.3.3 India Inflammatory Bowel Disease Treatment Market by Route of Administration
7.3.5.3.4 India Inflammatory Bowel Disease Treatment Market by Drug Class
7.3.5.4 South Korea Inflammatory Bowel Disease Treatment Market
7.3.5.4.1 South Korea Inflammatory Bowel Disease Treatment Market by Type
7.3.5.4.2 South Korea Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.3.5.4.3 South Korea Inflammatory Bowel Disease Treatment Market by Route of Administration
7.3.5.4.4 South Korea Inflammatory Bowel Disease Treatment Market by Drug Class
7.3.5.5 Singapore Inflammatory Bowel Disease Treatment Market
7.3.5.5.1 Singapore Inflammatory Bowel Disease Treatment Market by Type
7.3.5.5.2 Singapore Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.3.5.5.3 Singapore Inflammatory Bowel Disease Treatment Market by Route of Administration
7.3.5.5.4 Singapore Inflammatory Bowel Disease Treatment Market by Drug Class
7.3.5.6 Malaysia Inflammatory Bowel Disease Treatment Market
7.3.5.6.1 Malaysia Inflammatory Bowel Disease Treatment Market by Type
7.3.5.6.2 Malaysia Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.3.5.6.3 Malaysia Inflammatory Bowel Disease Treatment Market by Route of Administration
7.3.5.6.4 Malaysia Inflammatory Bowel Disease Treatment Market by Drug Class
7.3.5.7 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market
7.3.5.7.1 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market by Type
7.3.5.7.2 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.3.5.7.3 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market by Route of Administration
7.3.5.7.4 Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market by Drug Class
7.4 LAMEA Inflammatory Bowel Disease Treatment Market
7.4.1 LAMEA Inflammatory Bowel Disease Treatment Market by Type
7.4.1.1 LAMEA Crohn's Disease Market by Country
7.4.1.2 LAMEA Ulcerative Colitis Market by Country
7.4.2 LAMEA Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.4.2.1 LAMEA Hospital Pharmacy Market by Country
7.4.2.2 LAMEA Retail Pharmacy Market by Country
7.4.2.3 LAMEA Online Pharmacy Market by Country
7.4.3 LAMEA Inflammatory Bowel Disease Treatment Market by Route of Administration
7.4.3.1 LAMEA Injectable Market by Country
7.4.3.2 LAMEA Oral Market by Country
7.4.4 LAMEA Inflammatory Bowel Disease Treatment Market by Drug Class
7.4.4.1 LAMEA TNF inhibitors Market by Country
7.4.4.2 LAMEA Anti-integrin Market by Country
7.4.4.3 LAMEA IL inhibitors Market by Country
7.4.4.4 LAMEA Corticosteroids Market by Country
7.4.4.5 LAMEA JAK inhibitors Market by Country
7.4.4.6 LAMEA Aminosalicylates Market by Country
7.4.4.7 LAMEA Others Market by Country
7.4.5 LAMEA Inflammatory Bowel Disease Treatment Market by Country
7.4.5.1 Brazil Inflammatory Bowel Disease Treatment Market
7.4.5.1.1 Brazil Inflammatory Bowel Disease Treatment Market by Type
7.4.5.1.2 Brazil Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.4.5.1.3 Brazil Inflammatory Bowel Disease Treatment Market by Route of Administration
7.4.5.1.4 Brazil Inflammatory Bowel Disease Treatment Market by Drug Class
7.4.5.2 Argentina Inflammatory Bowel Disease Treatment Market
7.4.5.2.1 Argentina Inflammatory Bowel Disease Treatment Market by Type
7.4.5.2.2 Argentina Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.4.5.2.3 Argentina Inflammatory Bowel Disease Treatment Market by Route of Administration
7.4.5.2.4 Argentina Inflammatory Bowel Disease Treatment Market by Drug Class
7.4.5.3 UAE Inflammatory Bowel Disease Treatment Market
7.4.5.3.1 UAE Inflammatory Bowel Disease Treatment Market by Type
7.4.5.3.2 UAE Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.4.5.3.3 UAE Inflammatory Bowel Disease Treatment Market by Route of Administration
7.4.5.3.4 UAE Inflammatory Bowel Disease Treatment Market by Drug Class
7.4.5.4 Saudi Arabia Inflammatory Bowel Disease Treatment Market
7.4.5.4.1 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Type
7.4.5.4.2 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.4.5.4.3 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Route of Administration
7.4.5.4.4 Saudi Arabia Inflammatory Bowel Disease Treatment Market by Drug Class
7.4.5.5 South Africa Inflammatory Bowel Disease Treatment Market
7.4.5.5.1 South Africa Inflammatory Bowel Disease Treatment Market by Type
7.4.5.5.2 South Africa Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.4.5.5.3 South Africa Inflammatory Bowel Disease Treatment Market by Route of Administration
7.4.5.5.4 South Africa Inflammatory Bowel Disease Treatment Market by Drug Class
7.4.5.6 Nigeria Inflammatory Bowel Disease Treatment Market
7.4.5.6.1 Nigeria Inflammatory Bowel Disease Treatment Market by Type
7.4.5.6.2 Nigeria Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.4.5.6.3 Nigeria Inflammatory Bowel Disease Treatment Market by Route of Administration
7.4.5.6.4 Nigeria Inflammatory Bowel Disease Treatment Market by Drug Class
7.4.5.7 Rest of LAMEA Inflammatory Bowel Disease Treatment Market
7.4.5.7.1 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Type
7.4.5.7.2 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Distribution Channel
7.4.5.7.3 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Route of Administration
7.4.5.7.4 Rest of LAMEA Inflammatory Bowel Disease Treatment Market by Drug Class
Chapter 8. Company Profiles
8.1 Allergan PLC (AbbVie)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals and Trials:
8.2 Johnson & Johnson
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental &Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Approvals and Trials:
8.3 Merck Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisitions and Mergers:
8.3.5.3 Product Launches and Product Expansions:
8.4 Amgen, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisitions and Mergers:
8.4.5.3 Geographical Expansions:
8.4.5.4 Approvals and Trials:
8.5 Eli Lilly and Company
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expense
8.6 Biogen, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Approvals and Trials:
8.7 Pfizer, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisitions and Mergers:
8.7.5.2 Approvals and Trials:
8.8 Novartis AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Acquisitions and Mergers:
8.8.5.3 Approvals and Trials:
8.9 Takeda Pharmaceutical Company Limited
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.5.2 Acquisitions and Mergers:
8.9.5.3 Product Launches and Product Expansions:
8.9.5.4 Approvals and Trials:
8.10. UCB S.A.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Approvals and Trials:
Unique Offerings 